Latest Research

R D Heath et al, 2017. Coffee: The magical bean for liver disease, World Journal of Hepatology, Volume 9 (15)

L J M Alferink et al, 2017. Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study, Journal of Hepatology, published online.

A Hodge et al, 2017. Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B. Nutrients, Volume 9 (1).

K Wijarnpreecha et al, 2016. Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis, European Journal of Gastroenterology & Hepatology, published online.

S Ki Kim et al, 2016. Coffee intake and liver enzyme association in Korean immigrants and Japanese: a comprehensive cross-sectional study, Digestive Disorders, published online.

K Wijarnpreecha et al, 2016. Impact of caffeine on hepatitis C virus infection: a systematic review and meta-analysis. European Journal of Gastroenterology, published online.

V Jaruvongvanich et al, 2016. Effects of Caffeine Consumption in Patients with Chronic Hepatitis C: A Systematic Review and Meta-Analysis, Clin Res Hepatol Gastroenterol, published online ahead of print.

L Kirsty Pourshahidi et al, 2016. A Comprehensive Overview of the Risks and Benefits of Coffee Consumption, Comprehensive Reviews in Food Science and Food Safety, Volume 15.

M Wadhawan & A C Anand, 2016. Coffee and Liver Disease, Journal of Clinical and Experimental Hepatology, published online ahead of print.

S Marvento et al, 2016. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies. Clinical Nutrition, published online ahead of print.

This information is intended for Healthcare professional audiences.
Please consider the environment before printing.